If there was toxicity problem with azer-cel why would the FDA allow azer-cel to now be used with cf33?
azer-cell was a long trial with a different company, precision biosciences. Now imugene will use their progress with cart-t to further our plan to get cf33 into patients.
once again;
If there was toxicity problem with azer-cel why would the FDA...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
-0.002(3.51%) |
Mkt cap ! $402.5M | |||
| Open | High | Low | Value | Volume |
| 5.7¢ | 5.7¢ | 5.4¢ | $1.042M | 18.87M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 628179 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 897037 | 6 |
View Market Depth
| Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |